Canopy Growth Corporation (CGC) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's ...

Short-selling has been rampant in the cannabis sector, sometimes facilitated by company insiders lending their own shares to ...

In a report released on November 8, Lisa Lewandowski from Bank of America Securities reiterated a Sell rating on Canopy Growth (CGC – Research Report), with a price target of C$ ... dampen investor ...

It has experienced a hiccup, but the company is still on the right path. That’s the opinion of Roth MKM analyst Bill Kirk on ...

Canopy Growth's revenue and EBITDA have been disappointing, and analysts' projections for FY25 and FY26 remain weak. Read why ...

Canopy Growth ( (CGC) ) has released its Q2 earnings. Here is a breakdown of the information Canopy Growth presented to its investors. Canopy ...

Baxter International shares fell after it posted a drop in third-quarter earnings. Shares of cannabis producer Canopy Growth fell after a slowdown in adult marijuana use in Canada weighed on earnings.

My name is Nicole, and I will be your conference operator today. I would like to welcome you to Canopy Growth's second ...

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

Canopy saw a significant decline in Canadian adult-use cannabis, where revenue fell 24% to C$18.4 million. This offset the 16% gain from Canadian medical cannabis which reached C$18.7 million, and ...

Canopy Growth ( NASDAQ: CGC) is scheduled to announce Q2 earnings results on Friday, November 8th, before market open.

Analysts estimate that Canopy Growth will report an earnings per share (EPS) of $-0.32. The announcement from Canopy Growth is eagerly anticipated, with investors seeking news of surpassing estimates ...